Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nyan Latt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gastroenterology & Hepatology|January 8, 2013
Hepatitis C virus and its renal manifestations: a review and updateNyan Latt, Nada Alachkar, Ahmet Gurakar
Clinics in Liver Disease|March 28, 2024
Minimal Hepatic EncephalopathyRachel Redfield, Nyan Latt, Santiago J Munoz
Advances in Kidney Disease and Health|April 22, 2024
Pathophysiology of Hepatorenal SyndromeJuan Carlos Q Velez, Nyan Latt, Roger A Rodby
Endocrinology, Diabetes & Metabolism|July 12, 2025
Comparative Effectiveness of Bariatric Surgery Versus GLP-1 Receptor Agonists in Reducing the Risk of New-Onset of NASH: A Retrospective Multinational Cohort Study From North America and EuropeAbdallah Hussein, Ameer Awashra, Islam Rajab, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 19, 2012
A cohort study for derivation and validation of a clinical prediction scale for hospital-onset Clostridium difficile infectionSubhash Chandra, Nyan Latt, Ujjwal Jariwala, et al.
Digestive Diseases and Sciences|September 28, 2018
Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mLBeshoy Yanny, Sammy Saab, Francisco Durazo, et al.
Hepatology Communications|January 12, 2023
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD studyElizabeth S Aby, Ghady Moafa, Nyan Latt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gastroenterology & Hepatology|January 8, 2013
Hepatitis C virus and its renal manifestations: a review and updateNyan Latt, Nada Alachkar, Ahmet Gurakar
Clinics in Liver Disease|March 28, 2024
Minimal Hepatic EncephalopathyRachel Redfield, Nyan Latt, Santiago J Munoz
Advances in Kidney Disease and Health|April 22, 2024
Pathophysiology of Hepatorenal SyndromeJuan Carlos Q Velez, Nyan Latt, Roger A Rodby
Endocrinology, Diabetes & Metabolism|July 12, 2025
Comparative Effectiveness of Bariatric Surgery Versus GLP-1 Receptor Agonists in Reducing the Risk of New-Onset of NASH: A Retrospective Multinational Cohort Study From North America and EuropeAbdallah Hussein, Ameer Awashra, Islam Rajab, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 19, 2012
A cohort study for derivation and validation of a clinical prediction scale for hospital-onset Clostridium difficile infectionSubhash Chandra, Nyan Latt, Ujjwal Jariwala, et al.
Digestive Diseases and Sciences|September 28, 2018
Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mLBeshoy Yanny, Sammy Saab, Francisco Durazo, et al.
Hepatology Communications|January 12, 2023
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD studyElizabeth S Aby, Ghady Moafa, Nyan Latt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Pageof 1